These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 18603561

  • 1. Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98).
    Zenhäusern R, Simcock M, Gratwohl A, Hess U, Bargetzi M, Tobler A, Swiss Group for Clinical Cancer Research (SAKK).
    Haematologica; 2008 Sep; 93(9):1426-8. PubMed ID: 18603561
    [No Abstract] [Full Text] [Related]

  • 2. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment].
    Urasiński I, Zdziarska B, Krygier-Stojałowska A.
    Acta Haematol Pol; 1996 Sep; 27(1):49-55. PubMed ID: 8629443
    [Abstract] [Full Text] [Related]

  • 3. Cladribine in hairy cell leukemia.
    Belani R, Saven A.
    Hematol Oncol Clin North Am; 2006 Oct; 20(5):1109-23. PubMed ID: 16990111
    [Abstract] [Full Text] [Related]

  • 4. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
    Füreder W, Weltermann A, Chott A, Gisslinger H, Valent P, Jäger U, Geissler K, Lechner K.
    Wien Klin Wochenschr; 1999 Dec 23; 111(24):1027-30. PubMed ID: 10677889
    [Abstract] [Full Text] [Related]

  • 5. Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.
    Else M, Ruchlemer R, Osuji N, Del Giudice I, Matutes E, Woodman A, Wotherspoon A, Swansbury J, Dearden C, Catovsky D.
    Cancer; 2005 Dec 01; 104(11):2442-8. PubMed ID: 16245328
    [Abstract] [Full Text] [Related]

  • 6. Effect of 2-chlorodeoxyadenosine therapy on bone marrow fibrosis in hairy cell leukemia.
    Dedic K, Zák P.
    Neoplasma; 2004 Dec 01; 51(1):56-8. PubMed ID: 15004661
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of hairy cell leukemia with cladribine].
    Aurer I, Mitrović Z, Kovacević-Metelko J, Radman I, Basić-Kinda S, Gjadrov-Kuvezdić K, Jakić-Razumović J, Dubravcić K, Ries S, Nola M, Zupancic-Salek S, Labar B.
    Lijec Vjesn; 2007 Dec 01; 129(3-4):80-3. PubMed ID: 17557550
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Hairy cell leukemia therapy by cladribine].
    Ogura M.
    Nihon Rinsho; 2004 Jul 01; 62(7):1337-42. PubMed ID: 15283153
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of hair cell leukemia with 2-chlorodeoxyadenosine and G-CSF].
    Bengió R, Pérez M, Sarmiento M, Raña P, Sánchez Lucero A, Sarto A, Arrossagaray G.
    Medicina (B Aires); 1996 Jul 01; 56(5 Pt 1):534. PubMed ID: 9239892
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of hairy-cell leukemia: current views.
    Tallman MS, Peterson LC, Hakimian D, Gillis S, Polliack A.
    Semin Hematol; 1999 Apr 01; 36(2):155-63. PubMed ID: 10319384
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rituximab as treatment for minimal residual disease in hairy cell leukaemia.
    Cervetti G, Galimberti S, Andreazzoli F, Fazzi R, Cecconi N, Caracciolo F, Petrini M.
    Eur J Haematol; 2004 Dec 01; 73(6):412-7. PubMed ID: 15522063
    [Abstract] [Full Text] [Related]

  • 20. [Complete remission after Rituximab treatment in refractory hairy cell leukemia].
    Petruskevicius I, Bukh A, Mertz H, Johnsen HE.
    Ugeskr Laeger; 2008 Jun 23; 170(26-32):2350. PubMed ID: 18570771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.